CS Medica A/S

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

N/A

SEDOL

N/A

CIK

N/A

www.cs-medica.com

LEI:

CS Medica is a Member of Themefolio

Cannabis

FIGI: BBG0124SHSL5

CSMED

CS Medica A/S

GICS: - · Sector: - · Sub-Sector: -

PROFILER

NAME

CS Medica A/S

ISIN

DK0061668225

TICKER

CSMED

MIC

XNGM

REUTERS

CSMED

BLOOMBERG

CSMED

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.

Mon, 04.11.2024

Original-Research: CS MEDICA A/S - from NuWays AG 04.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange tr...

Research & Analysis

Mon, 01.07.2024

The shares of CS MEDICA A/S (ISIN DK0061668225) have been listed on the Frankfurt Stock Exchange since March 2, 2023. The company, a MedTech pioneer in the development of medical devices that benefit from bioactive CBD, has mandated the private bank Hauck Aufhäuser Lampe to include the company's shares in Deutsche Börse AG's trading venue XETRA and...

Research & Analysis

Mon, 17.06.2024

Strategic Milestone Achieved as CANNORDIC, a CS MEDICA Subsidiary, Navigates Regulatory Challenges to Expand Global Footprint CS MEDICA Group, a leader in innovative substance-based medical devices containing bioactive CBD, is proud to announce the successful completion of the product registration process for its entire CANNASEN® portfolio o...

Research & Analysis

Mon, 17.06.2024

Research & Analysis

Mon, 10.06.2024

CS MEDICA A/S, a pioneering MedTech company specializing in innovative substance-based medical devices containing bioactive CBD, today announced its plans to spin off and list its subsidiary CANNORDIC A/S on the German Stock Market (Intention to Float). CS MEDICA ("CS MEDICA" or "The Company") aims to elevate the value of CS MEDICA's shares, ta...

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

CS Medica A/S

Buy

CS MEDICA Stock Now Also Traded on XETRA

CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel

CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel

CS MEDICA A/S Plans Stock Spin-Off and Listing of CANNORDIC A/S

Newsletter